Sommerburg, Olaf <br/><br/>
Initial evaluation of a biochemical cystic fibrosis newborn screening by sequential analysis of immunoreactive trypsinogen and pancreatitis-associated protein (IRT/PAP) as a strategy that does not involve DNA testing in a Northern European population.  [electronic resource] 

 -  Journal of inherited metabolic disease  Oct 2010 
 - S263-71 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-2665 
<br/><br/><label>Standard No.: </label>10.1007/s10545-010-9174-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigens, Neoplasm--blood<br/>Biomarkers--blood<br/>Biomarkers, Tumor--blood<br/>Chlorides--analysis<br/>Cystic Fibrosis--blood<br/>Cystic Fibrosis Transmembrane Conductance Regulator--genetics<br/>Enzyme-Linked Immunosorbent Assay<br/>Genetic Testing<br/>Germany<br/>Humans<br/>Infant, Newborn<br/>Lectins, C-Type--blood<br/>Mutation<br/>Neonatal Screening--methods<br/>Pancreatitis-Associated Proteins<br/>Predictive Value of Tests<br/>Program Evaluation<br/>Prospective Studies<br/>Sensitivity and Specificity<br/>Sweat--chemistry<br/>Trypsinogen--blood